Hello, my dears,
Siemens is a must-have for me, so I'm staying invested.
Siemens and Merck have deepened their strategic partnership through a new Memorandum of Understanding to accelerate the digital transformation in the life science industry.
The Memorandum of Understanding (MoU) focuses on the development of integrated software solutions based on automation, data and artificial intelligence (AI). The aim is to network research, development and production of new active ingredients more closely and thus accelerate them. The partnership marks the first use of the technology that Siemens acquired as part of the Dotmatics takeover in July 2025.
As part of the partnership, digital solutions will be developed to close existing gaps in drug discovery and biotech manufacturing workflows. To this end, Software-as-a-Service (SaaS) products from Merck will be linked with the Siemens digital ecosystem. As part of an initial pilot project, Merck's AI tools and digital applications will be made available in Luma. Luma is an AI-supported software (Scientific Intelligence Platform) from Siemens that was acquired with the Dotmatics takeover. It will enable scientists to order products in a single environment while accessing the digital tools and relevant information they need to make faster, data-driven decisions.
Building on this pilot project, Siemens and Merck are planning further joint projects and aiming for even closer integration in the long term, such as intelligent data management tools and user-friendly interfaces that make it easier for scientists to use complex procedures. In addition, both partners are exploring the development of digital marketplaces through which customers can access complementary technologies and services.
